Cameroon Mobile Phone SMS Trial

Conditions

Adherence, HIV

Keywords

compliance, observance, mobile phone, SMS, text message, ARV, HAART, AIDS

Brief summary

The investigators hypothesize that sending weekly motivational text messages to people infected with HIV will encourage them to take their medication, compared to usual care.

Mbuagbaw L, Thabane L, Ongolo-Zogo P.

2013-04-0419 citations

10.1186/1756-0500-6-131

The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy.

Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills EJ, Smieja M, Dolovich L, Kouanfack C.

2012-12-06171 citations

10.1371/journal.pone.0046909

The Cameroon mobile phone SMS (CAMPS) trial: a protocol for a randomized controlled trial of mobile phone text messaging versus usual care for improving adherence to highly active anti-retroviral therapy.

Mbuagbaw L, Thabane L, Ongolo-Zogo P, Lester RT, Mills E, Volmink J, Yondo D, Essi MJ, Bonono-Momnougui RC, Mba R, Ndongo JS, Nkoa FC, Ondoa HA.

2011-01-0745 citations

10.1186/1745-6215-12-5

Interventions

OTHERMobile phone text message

Weekly message with motivational content

OTHERUsual care

Usual care provided at clinic

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

21 Years to 65 Years

Healthy volunteers

No

Inclusion criteria

* On HAART for at least 1 month * 21 years or more * Owns a mobile phone * Can read text messages

Exclusion criteria

* On HAART for less than 1 month * Aged less than 21 years

Design outcomes

Primary

Measure	Time frame	Description
Adherence	Change from baseline at 6 months	Measured using the Visual Analogue Scale, Self Report and Pharmacy Refill Data

Secondary

Measure	Time frame	Description
Body Mass Index	Change from baseline at 6 months	—
CDC classification	Change from baseline at 6 months	—
WHO Classification	Change from baseline at 6 months	—
Weight	Change from baseline at 6 months	—
CD4 count	Change from baseline at 6 months	—
Viral load	Change from baseline at 6 months	—
Quality of life	Change from baseline at 6 months	Measured using the SF-12 quality of life form
Mortality	6 months	All cause mortality

Countries

Cameroon

Outcome results

None listed